Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

22.9K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.9K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

3.4K
3.4K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.1K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nonlinear combinatorial analysis of blood transcriptomes identifies PRKAR1A as a regulator of TDP-43 pathophysiology in amyotrophic lateral sclerosis.

Biology methods & protocols·2026
Same author

Laminaran Attenuates NaCl-Induced Cytotoxicity via ROS Scavenging and Prevents Alteration of Cellular Elastic Modulus.

Marine drugs·2026
Same author

Nanofiber-based platform for quantitative analysis of human oligodendrocyte ensheathment with pharmacological perturbations.

Stem cell reports·2026
Same author

Phenotypic screening of human iPSC-derived neurons identifies thienopyridones as neuritogenic small molecules.

iScience·2026
Same author

Senhance-assisted thoracoscopic surgery for mediastinal tumor.

Journal of cardiothoracic surgery·2026
Same author

Dissecting microglial contributions to neurodegenerative disease pathophysiology using human pluripotent stem cells.

Stem cell reports·2026

Related Experiment Video

Updated: May 3, 2026

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
12:40

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

9.7K

iPS cells: a game changer for future medicine.

Haruhisa Inoue1, Naoki Nagata, Hiromi Kurokawa

  • 1Center for iPS Cell Research and Application(CiRA), Kyoto University, Kyoto, Japan.

The EMBO Journal
|February 7, 2014
PubMed
Summary

Induced pluripotent stem cells (iPSCs) revolutionize disease modeling and cell transplantation. iPSC technology enables personalized medicine by predicting drug responses and improving clinical trial success rates.

More Related Videos

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.7K
Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System
08:00

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System

Published on: May 14, 2015

34.5K

Related Experiment Videos

Last Updated: May 3, 2026

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
12:40

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

9.7K
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.7K
Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System
08:00

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System

Published on: May 14, 2015

34.5K

Area of Science:

  • Regenerative Medicine
  • Stem Cell Biology
  • Translational Medicine

Background:

  • Induced pluripotent stem cell (iPSC) technology is a cornerstone for advancing disease modeling and cell transplantation.
  • Previous reports highlight challenges and opportunities in these fields.
  • The integration of iPSCs into clinical applications is rapidly evolving.

Purpose of the Study:

  • To review current issues in iPSC-based disease modeling and cell transplantation.
  • To explore novel applications of iPSC technology in medicine, including clinical trials.
  • To discuss the potential of iPSCs to bridge the gap between drug discovery (micromedicine) and clinical application (macromedicine).

Main Methods:

  • Review of existing literature on iPSC applications in disease modeling and transplantation.
  • Analysis of iPSC-based strategies for drug response prediction and patient stratification.
  • Discussion of iPSC-derived cells in identifying drug response markers.

Main Results:

  • iPSCs facilitate accurate disease modeling and hold promise for cell transplantation therapies.
  • Patient-derived iPSCs can predict drug efficacy and stratify patients in clinical trials.
  • iPSC-derived cells aid in identifying biomarkers for drug responsiveness, enhancing trial success.

Conclusions:

  • iPSC technology offers transformative potential for personalized medicine, from drug discovery to clinical trials.
  • The application of iPSCs in disease modeling, transplantation, and clinical trials signifies a paradigm shift in medical practice.
  • iPSCs effectively connect micromedicine (drug discovery) and macromedicine (clinical trials), heralding a new era in healthcare.